
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.460 | 0.460 | 0.000 |
Shares | 99.540 | 99.540 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.164 | 13.192 |
Price to Book | 2.207 | 1.816 |
Price to Sales | 1.060 | 1.180 |
Price to Cash Flow | 9.452 | 7.662 |
Dividend Yield | 2.528 | 3.030 |
5 Years Earnings Growth | 11.118 | 9.179 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 24.390 | 14.805 |
Consumer Cyclical | 18.370 | 10.057 |
Technology | 14.790 | 14.398 |
Basic Materials | 14.080 | 5.432 |
Consumer Defensive | 10.310 | 9.576 |
Industrials | 7.790 | 12.393 |
Utilities | 3.720 | 4.449 |
Energy | 3.540 | 5.450 |
Communication Services | 3.000 | 8.170 |
Number of long holdings: 108
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AutoZone Inc | - | 1.17 | - | - | |
Pfizer Inc | - | 1.16 | - | - | |
Biogen Inc | - | 1.16 | - | - | |
Regeneron Pharmaceuticals Inc | - | 1.16 | - | - | |
Apple Inc | - | 1.15 | - | - | |
Celgene Corp | - | 1.14 | - | - | |
Roche Holding Participation | CH0012032048 | 1.13 | 260.30 | 0.00% | |
Marathon Petroleum Corp | - | 1.13 | - | - | |
Target Corp | - | 1.13 | - | - | |
Novartis | CH0012005267 | 1.12 | 101.16 | 0.00% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DeutscheInv I GlblInfra USD LC | 2.46B | 10.12 | 3.50 | 5.07 | ||
DeutscheInv I GlblInfra USD FC | 2.46B | 10.61 | 4.29 | 5.86 | ||
DeutscheInv I GlblInfra USD ID | 2.46B | 10.71 | 4.47 | - | ||
DeutscheInv I GlblInfra USD LD | 2.46B | 10.12 | 3.50 | - | ||
DeutscheInv I GlblInfra USD FDM | 2.46B | 10.61 | 4.28 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review